David Harding - Net Worth and Insider Trading
David Harding Net Worth
The estimated net worth of David Harding is at least $5 Million dollars as of 2024-11-08. David Harding is the SVP, International of Hologic Inc and owns about 57,169 shares of Hologic Inc (HOLX) stock worth over $5 Million. David Harding is also the Chief Commercial Officer of Millendo Therapeutics Inc and owns about 10 shares of Millendo Therapeutics Inc (MLND) stock worth over $11. Details can be seen in David Harding's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Harding has not made any transactions after 2014-04-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Harding
David Harding Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Harding owns 4 companies in total, including T2 Biosystems Inc (TTOO) , Millendo Therapeutics Inc (MLND) , and Hologic Inc (HOLX) among others .
Click here to see the complete history of David Harding’s form 4 insider trades.
Insider Ownership Summary of David Harding
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TTOO | T2 Biosystems Inc | 2015-10-30 | Chief Commercial Officer |
| MLND | Millendo Therapeutics Inc | 2014-12-09 | Chief Commercial Officer |
| HOLX | Hologic Inc | 2012-09-07 | SVP & International |
 | | 2014-12-08 | Chief Commercial Officer |
David Harding Latest Holdings Summary
David Harding currently owns a total of 2 stocks. Among these stocks, David Harding owns 57,169 shares of Hologic Inc (HOLX) as of September 7, 2012, with a value of $5 Million and a weighting of 100%. David Harding also owns 10 shares of Millendo Therapeutics Inc (MLND) as of April 10, 2014, with a value of $11 and a weighting of 0%.
Latest Holdings of David Harding
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HOLX | Hologic Inc | 2012-09-07 | 57,169 | 79.29 | 4,532,930 |
| MLND | Millendo Therapeutics Inc | 2014-04-10 | 10 | 1.06 | 11 |
Holding Weightings of David Harding
David Harding Form 4 Trading Tracker
According to the SEC Form 4 filings, David Harding has made a total of 0 transactions in Hologic Inc (HOLX) over the past 5 years. The most-recent trade in Hologic Inc is the sale of 7,800 shares on September 7, 2012, which brought David Harding around $157,170.
According to the SEC Form 4 filings, David Harding has made a total of 0 transactions in Millendo Therapeutics Inc (MLND) over the past 5 years. The most-recent trade in Millendo Therapeutics Inc is the acquisition of 4 shares on April 10, 2014, which cost David Harding around $32,230.
Insider Trading History of David Harding
- 1
David Harding Trading Performance
GuruFocus tracks the stock performance after each of David Harding's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Harding is 4.3%. GuruFocus also compares David Harding's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Harding within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Harding's insider trading performs compared to the benchmark.
Performance of David Harding
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -20.53 | | | | | |
| Relative Return to S&P 500(%) | -23.01 | | | | | |
David Harding Ownership Network
Ownership Network List of David Harding
Ownership Network Relation of David Harding
David Harding Owned Company Details
What does T2 Biosystems Inc do?
Who are the key executives at T2 Biosystems Inc?
David Harding is the Chief Commercial Officer of T2 Biosystems Inc. Other key executives at T2 Biosystems Inc include 10 percent owner Cr Group L.p. , 10 percent owner Crg Partners Iii (cayman) Unlev Aiv I L.p. , and 10 percent owner Crg Partners Iii (cayman) Lev Aiv I L.p. .
T2 Biosystems Inc (TTOO) Insider Trades Summary
Over the past 18 months, David Harding made no insider transaction in T2 Biosystems Inc (TTOO). Other recent insider transactions involving T2 Biosystems Inc (TTOO) include a net sale of 48,345,798 shares made by Cr Group L.p. , and a net sale of 55 shares made by David B Elsbree .
In summary, during the past 3 months, insiders sold 55 shares of T2 Biosystems Inc (TTOO) in total and bought 0 shares, with a net sale of 55 shares. During the past 18 months, 483,513 shares of T2 Biosystems Inc (TTOO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 483,513 shares.
T2 Biosystems Inc (TTOO)'s detailed insider trading history can be found in Insider Trading Tracker table.
T2 Biosystems Inc Insider Transactions
David Harding Mailing Address
Above is the net worth, insider trading, and ownership report for David Harding. You might contact David Harding via mailing address: C/o Hologic, Inc., Bedford Ma 01730.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
